These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

97 related items for PubMed ID: 1501222

  • 1. Molecular determinants of the platelet aggregation inhibitory activity of carbamoylpiperidines.
    Feng Z, Gollamudi R, Dillingham EO, Bond SE, Lyman BA, Purcell WP, Hill RJ, Korfmacher WA.
    J Med Chem; 1992 Aug 07; 35(16):2952-8. PubMed ID: 1501222
    [Abstract] [Full Text] [Related]

  • 2. Enantioselective antiplatelet actions of nipecotamides.
    Gollamudi R, Feng Z, Dillingham EO, Bond SE, Han G, Salgia S.
    Thromb Res; 1993 Feb 15; 69(4):361-7. PubMed ID: 8470057
    [Abstract] [Full Text] [Related]

  • 3. New carbamoylpiperidines as human platelet aggregation inhibitors.
    Guo Z, Zheng X, Thompson W, Dugdale M, Gollamudi R.
    Bioorg Med Chem; 2000 May 15; 8(5):1041-58. PubMed ID: 10882016
    [Abstract] [Full Text] [Related]

  • 4. Inhibition of PAF-induced human platelet aggregation by antithrombotic nipecotomides.
    Herron D, Dillingham EO, Lyman BA, Zheng X, Bond SE, Salgia SR, Gollamudi R.
    Prostaglandins Leukot Essent Fatty Acids; 1995 May 15; 52(5):309-18. PubMed ID: 7630919
    [Abstract] [Full Text] [Related]

  • 5. Design and synthesis of piperidine-3-carboxamides as human platelet aggregation inhibitors.
    Zheng X, Salgia SR, Thompson WB, Dillingham EO, Bond SE, Feng Z, Prasad KR, Gollamudi R.
    J Med Chem; 1995 Jan 06; 38(1):180-8. PubMed ID: 7837229
    [Abstract] [Full Text] [Related]

  • 6. Investigation of platelet aggregation inhibitory activity by phenyl amides and esters of piperidinecarboxylic acids.
    de Candia M, Summo L, Carrieri A, Altomare C, Nardecchia A, Cellamare S, Carotti A.
    Bioorg Med Chem; 2003 Apr 03; 11(7):1439-50. PubMed ID: 12628670
    [Abstract] [Full Text] [Related]

  • 7. Antiplatelet effects of R,S-(meso)-alpha, alpha'-bis[3-(N,N-diethylcarbamoyl) piperidino]-p-xylene ex vivo in the dog and in vivo in the mouse.
    Han G, Bannerman D, Handa RK, Dillingham EO, Lawrence WH, Gollamudi R.
    Gen Pharmacol; 1997 Apr 03; 28(4):617-21. PubMed ID: 9147034
    [Abstract] [Full Text] [Related]

  • 8. Stereoselective inhibition of human platelet aggregation by R-138727, the active metabolite of CS-747 (prasugrel, LY640315), a novel P2Y12 receptor inhibitor.
    Hasegawa M, Sugidachi A, Ogawa T, Isobe T, Jakubowski JA, Asai F.
    Thromb Haemost; 2005 Sep 03; 94(3):593-8. PubMed ID: 16268477
    [Abstract] [Full Text] [Related]

  • 9. Chiral resolution of alpha,alpha'-bis[3-(N,N-diethylcarbamoyl)piperidino]-p-xylene, a novel antiplatelet compound.
    Gollamudi R, Feng ZX.
    Chirality; 1991 Sep 03; 3(6):480-3. PubMed ID: 1812959
    [Abstract] [Full Text] [Related]

  • 10. Chiral resolution and absolute configuration of the enantiomers of 5-acetyl-2-methyl-4-methylsulfinyl-6-phenyl-3(2H)-pyridazinone and evaluation of their platelet aggregation inhibitory activity.
    Azzolina O, Dal Piaz V, Collina S, Giovannoni MP, Tadini C.
    Chirality; 1997 Sep 03; 9(7):681-5. PubMed ID: 9366028
    [Abstract] [Full Text] [Related]

  • 11. Inhibitory effects of H2-receptor antagonists on platelet function in vitro.
    Nakamura K, Kariyazono H, Shinkawa T, Yamaguchi T, Yamashita T, Ayukawa O, Moriyama Y, Yotsumoto G, Toyohira H, Taira A, Yamada K.
    Hum Exp Toxicol; 1999 Aug 03; 18(8):487-92. PubMed ID: 10462360
    [Abstract] [Full Text] [Related]

  • 12. Stereochemistry and biological activities of constituents from Cynanchum taiwanianum.
    Lin CN, Huang PL, Wang JJ, Day SH, Lin HC, Wang JP, Ko YL, Teng CM.
    Biochim Biophys Acta; 1998 Mar 12; 1380(1):115-22. PubMed ID: 9545557
    [Abstract] [Full Text] [Related]

  • 13. Adenosine receptor agonists: synthesis and biological evaluation of the diastereoisomers of 2-(3-hydroxy-3-phenyl-1-propyn-1-yl)NECA.
    Camaioni E, Di Francesco E, Vittori S, Volpini R, Cristalli G.
    Bioorg Med Chem; 1997 Dec 12; 5(12):2267-75. PubMed ID: 9459024
    [Abstract] [Full Text] [Related]

  • 14. Antiplatelet activity of nipecotamides in experimental thrombosis in mice.
    Lawrence WH, Howell RD, Gollamudi R.
    J Pharm Sci; 1994 Feb 12; 83(2):222-5. PubMed ID: 8169794
    [Abstract] [Full Text] [Related]

  • 15. Inhibitory effect of sulfur-containing compounds in Scorodocarpus borneensis Becc. on the aggregation of rabbit platelets.
    Lim H, Kubota K, Kobayashi A, Seki T, Ariga T.
    Biosci Biotechnol Biochem; 1999 Feb 12; 63(2):298-301. PubMed ID: 10192909
    [Abstract] [Full Text] [Related]

  • 16. In vitro effects of aprosulate sodium, a novel anticoagulant, on platelet activation: possible mechanism for antiplatelet action.
    Sugidachi A, Breiter N, Ogawa T, Asai F, Koike H.
    Thromb Haemost; 1996 Nov 12; 76(5):786-90. PubMed ID: 8950791
    [Abstract] [Full Text] [Related]

  • 17. Specific inhibition of ADP-induced platelet aggregation by clopidogrel in vitro.
    Weber AA, Reimann S, Schrör K.
    Br J Pharmacol; 1999 Jan 12; 126(2):415-20. PubMed ID: 10077233
    [Abstract] [Full Text] [Related]

  • 18. Design and synthesis of novel imidazole-substituted dipeptide amides as potent and selective inhibitors of Candida albicans myristoylCoA:protein N-myristoyltransferase and identification of related tripeptide inhibitors with mechanism-based antifungal activity.
    Devadas B, Freeman SK, Zupec ME, Lu HF, Nagarajan SR, Kishore NS, Lodge JK, Kuneman DW, McWherter CA, Vinjamoori DV, Getman DP, Gordon JI, Sikorski JA.
    J Med Chem; 1997 Aug 01; 40(16):2609-25. PubMed ID: 9258368
    [Abstract] [Full Text] [Related]

  • 19. In vitro and in vivo activities of the novel antiplatelet agent alpha,alpha'-bis[3-(N,N-diethylcarbamoyl)piperidino]-p-xylene dihydrobromide.
    Lyman BA, Bond SE, Dillingham EO, Lawrence WH, Gollamudi R.
    Res Commun Chem Pathol Pharmacol; 1992 Dec 01; 78(3):279-88. PubMed ID: 1475529
    [Abstract] [Full Text] [Related]

  • 20. Inhibition of agonist-induced rise in platelet Ca2+ by antithrombotic nipecotamides.
    Gollamudi R, Dillingham EO, Bond SE.
    Blood Coagul Fibrinolysis; 1994 Jun 01; 5(3):375-83. PubMed ID: 8075309
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.